Abstract
Effects of nerve growth factor (NGF), adenosine and an adenosine A(2A) receptor agonist (CGS 21680) on the phosphorylation of extracellular-regulated kinases 1/2 (ERK1/2) were examined in PC12 cells. Adenosine and CGS 21680stimulated ERK1/2, but inhibited the phosphorylation of ERK1/2 induced by a 10 min incubation with NGF. Longer treatment with CGS 21680 and NGF (1-2h) resulted in an additive effect on the activation of ERK1/2. Forskolin exerted the same effects, suggesting that they are mediated by cyclic AMP. These results indicate that adenosine A(2A) receptor induced increases in cyclic AMP can stimulate ERK1/2 phosphorylation per se, inhibit the initial and enhance the late NGF-induced activation of ERK1/2. These results may be explained by the fact that NGF action is mediated via different pathways at early and late time points.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenosine / analogs & derivatives*
-
Adenosine / metabolism
-
Adenosine / pharmacology
-
Animals
-
Colforsin / pharmacology
-
Cyclic AMP / metabolism
-
Drug Synergism
-
Mitogen-Activated Protein Kinase 1 / metabolism*
-
Mitogen-Activated Protein Kinase 3
-
Mitogen-Activated Protein Kinases / metabolism*
-
Nerve Growth Factor / metabolism*
-
Nerve Growth Factor / pharmacology
-
PC12 Cells
-
Phenethylamines / pharmacology
-
Phosphorylation / drug effects
-
Purinergic P1 Receptor Agonists
-
Rats
-
Receptor, Adenosine A2A
-
Receptors, Purinergic P1 / metabolism*
-
Signal Transduction / drug effects
Substances
-
Phenethylamines
-
Purinergic P1 Receptor Agonists
-
Receptor, Adenosine A2A
-
Receptors, Purinergic P1
-
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine
-
Colforsin
-
Nerve Growth Factor
-
Cyclic AMP
-
Mitogen-Activated Protein Kinase 1
-
Mitogen-Activated Protein Kinase 3
-
Mitogen-Activated Protein Kinases
-
Adenosine